1Apple FS, Pearce LA, Chung A, et al. Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome[ J]. Clin chem ,2007 ,53 (5) :874-881.
5Ridker PM, Cushman M, Stempfer M J, et al. Plasma concentration of C - reaction protein and risk of developing peripheral vascular disease [ J ]. Circulation, 1998,97 (5):425-428.
2Hopkins PN,Williams RR. A survey of 246 suggested coronary risk factors[J]. Atherosclerosis, 1981,40:1-52.
3EUROASPIRE:a Europan Society of Cardiology survery of secondary prevention of coronary heart disease: principal results[J]. Eur Heart J, 1997,18:1569-1582.
4Ross R. Atheroslerosis-an inflammatory disease[J]. N Engl J Med, 1999,340:115-126.
5Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis [ J]. Circulation, 2001,103 :1194-1197.
6Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex,and hormone replacement treatment [J]. Circulation, 2000,101:1785-1791.
7Penn MS, Topol EJ. Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling[J]. Cir Res, 2001,89:1-2.
8Yasojima K,Schwab C, McGeer EG, et al. Generation of C-Reactive protein and complement components in atheroscle-rotic plaques[J]. Am J Pathol,2001,158 : 1039-1051.
9Tomai F,Crea F,Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasore-activity of the culprit lesion [J]. Circulation, 2001, 104 :1471-1476.
10Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells[J].Circulation, 2000,102 : 2165-2168.
